ARA-04

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameARA-04
Drug Alias NameL-methionine gamma-lyase inhibitor (aRigen)ARA-04
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLyases inhibitors
TargetsLyases
Therapy Area/IndicationsEntamoebiasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesArigen Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArigen Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsEntamoebiasis

Other Information

ATC CodeN/A
Related LinksN/A